Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Genmab stock have an average target of 45.2, with a low estimate of 32 and a high estimate of 50. The average target predicts an increase of 64.60% from the current stock price of 27.46.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$32	$45.2	$48	$50
Change	+16.53%	+64.60%	+74.80%	+82.08%

Analyst Ratings

The average analyst rating for Genmab stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	1	1	1
Hold	0	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+82.08%	Apr 4, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $50	Strong Buy	Maintains	$50	+82.08%	Mar 27, 2024
Matthew Harrison Morgan Stanley	Morgan Stanley	Sell Maintains $32	Sell	Maintains	$32	+16.53%	Mar 26, 2024
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $50	Strong Buy	Maintains	$50	+82.08%	Mar 26, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+82.08%	Mar 6, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

16.70B

Increased by 15.13%

from 14.51B

Revenue Next Year

20.09B

Increased by 20.28%

from 16.70B

EPS This Year

77.96

Increased by 843.98%

from 8.26

EPS Next Year

82.89

Increased by 6.32%

from 77.96

Year	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	3.03B	5.37B	10.11B	8.42B	14.51B	16.70B	20.09B	23.85B	27.58B	32.72B	39.44B
Revenue Growth	27.91%	77.39%	88.43%	-16.75%	72.33%	15.13%	20.28%	18.73%	15.66%	18.61%	20.56%
EPS	2.37	3.40	7.22	4.48	8.26	77.96	82.89	109.74	138.70	202.94	261.62
EPS Growth	33.54%	43.40%	112.20%	-38.00%	84.48%	843.98%	6.32%	32.39%	26.40%	46.31%	28.91%
No. Analysts	-	-	-	-	-	28	28	28	17	10	6

Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2023	2024	2025	2026	2027	2028
High	17.5B	22.0B	26.9B	32.1B	41.2B	51.2B
Avg	16.7B	20.1B	23.8B	27.6B	32.7B	39.4B
Low	15.8B	18.1B	20.9B	20.6B	26.3B	28.4B

Revenue Growth

Revenue Growth	2023	2024	2025	2026	2027	2028
High	20.7%	31.9%	34.0%	34.4%	49.5%	56.6%
Avg	15.1%	20.3%	18.7%	15.7%	18.6%	20.6%
Low	8.8%	8.4%	4.1%	-13.5%	-4.6%	-13.3%

EPS Forecast

EPS	2023	2024	2025	2026	2027	2028
High	89.31	96.58	131.46	176.20	316.89	395.55
Avg	77.96	82.89	109.74	138.70	202.94	261.62
Low	67.30	64.68	79.48	107.80	151.77	184.46

EPS Growth

EPS Growth	2023	2024	2025	2026	2027	2028
High	981.4%	23.9%	58.6%	60.6%	128.5%	94.9%
Avg	844.0%	6.3%	32.4%	26.4%	46.3%	28.9%
Low	714.8%	-17.0%	-4.1%	-1.8%	9.4%	-9.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.